A61M5/347

Detachable Needle Syringe Having Reduced Dead Space

A syringe and detachable needle assembly having reduced dead space features includes an elongate syringe barrel having open distal end including a collar and a distally facing annular surface projecting inwardly from the collar. A needle assembly includes a hub having a proximally facing annular surface and an outwardly projecting annular sealing ring positioned distally from the surface. The needle assembly also includes a cannula having a lumen therethrough connected to the distal end of the hub. Structure is provided for engaging the hub to the barrel resulting in the annular surface of the barrel contacting the annular surface of the hub to form a primary seal between said barrel and said hub and the annular sealing ring contacting the collar to form a secondary seal between the barrel and the hub.

Needle assembly
11331439 · 2022-05-17 ·

A needle assembly includes a needle, a rear needle cap and a front needle cap. The needle includes a needle hub and a needle shaft running through and attached to the needle hub. The shaft incorporates two sharp ends and an internal channel running through the entire length of the shaft. The needle hub includes a rear needle body and a front needle body. The rear needle cap is adapted to be attached to the rear needle body and the front needle cap is adapted to be attached to the front needle body. The front needle body incorporates a guiding channel and a locking receptacle connecting to and extending from the guiding channel in a needle detachment direction. The front needle cap includes an internal locking plug adapted to move along the guiding channel and be disposed inside the locking receptacle. The front needle cap also incorporates a funnel lip.

Safety Needle and Safety Needle Device
20220143325 · 2022-05-12 ·

A safety needle (10) and a safety needle device (1). The safety needle device (1) comprises the safety needle (10), an outer protective cover (60), and a sealing membrane (70). The outer protective cover (60) cooperates with the sealing membrane (70) to seal and package the safety needle (10). The safety needle (10) comprises a needle sleeve housing (20), a syringe assembly holder (40), a needle (30), and an elastic safety cover (50). The syringe assembly holder (40) is provided at a rear end of the needle sleeve housing (20). The needle (30) is movably provided inside the needle sleeve housing (20) and the syringe assembly holder (40). The elastic safety cover (50) is provided in the needle sleeve housing (20) so as to be capable of rotating and extending and retracting. A non-return guide slot (23) having a non-return elastic plate (235) in the needle sleeve housing (20) guides a needle sheath elastic engagement component (55) of a needle sheath (51) of the elastic safety cover (50) such that the elastic safety cover (50) can extend and retract in an axial direction of the needle sleeve housing (20) and control the timing of the extension of the needle (30) outside the elastic safety cover (50). After use, the elastic safety cover (50) covering an outer side of the needle (30) can be stopped and locked in the needle sleeve housing (20) by the non-return elastic plate (235) such that the safety needle (10) cannot be used again, thus ensuring safety of use.

CARTRIDGE BASED AUTO-INJECTOR
20220143317 · 2022-05-12 · ·

The present invention is an auto-injector for the administration and self-administration of drugs by subcutaneous, intramuscular or intra-dermal injection and for drug solutions or suspensions. The auto-injector may comprise three modules for ease of assembly, the modules principally including a standard cartridge module with stopper and septum, a power source and indicator module that pushes against the cartridge stopper pressurizing contents, an injection progress indicator and a needle shuttle comprising of two needles, one needle being the injection needle and one needle being the septum needle. A needle guard ensures that the needle is always covered thus hiding the needle before and after the injection and that prevents needle stick injurie.

SYSTEM AND METHOD FOR MULTIPLE SITE INJECTION

A system for injecting includes a syringe body having proximal and distal ends, a syringe interior, and a syringe flange at the proximal end thereof. The system also includes an injectable fluid disposed in the syringe interior. The system further includes a finger flange coupled to the syringe flange. Moreover, the system includes a stopper member disposed in the syringe interior. In addition, the system includes a plunger ratchet member coupled to the stopper member. The system also includes a plunger tube disposed coaxially around at least a portion of the plunger ratchet member and operatively coupled thereto.

Needle Actuator Assembly for Drug Delivery System

A needle actuator assembly for a drug delivery system includes a needle actuator body having a guide surface, a needle shuttle having a cam surface, with the needle shuttle moveable along a vertical axis between a first position and a second position. The needle shuttle is configured to move between the first and second position through engagement between the guide surface of the needle actuator body and the cam surface of the needle shuttle. The assembly further including a needle received by the needle shuttle.

Systems and methods for medicine delivery

Improved systems and methods for medicine delivery, and in particular, improved insulin pen needles and related devices are provided. Smart injection devices record and transfer data including medicine level, delivered dose, dose confirmation, and dose time and date. Additional data captured may include glucose concentration, insulin level, carbohydrates ingested, stress level, exercise, blood pressure, and glucose high and low excursion events. Various means of data collection and analysis are provided and systems can identify and flag patients who require intervention. Smart sleeves and add sensing capability to standard insulin pens. Pen needles are provided with sensing capability to confirm and measure doses delivered by insulin pen. A two-part pen cap include a primary sleeve that connects to the insulin pen and an end cap that provides for capturing the time of dose delivery, and monitoring the hold time for a dose delivery after plunger movement.

Medical Container, an Adaptor for Mounting Onto Said Medical Container, and a Drug Delivery Device Comprising Said Medical Container
20230241325 · 2023-08-03 ·

This medical container forms a reservoir for containing a medical product and has a longitudinal distal tip extending along a longitudinal axis. The distal tip defines a passageway in fluid communication with said reservoir. The distal tip includes a fitting portion configured to fit with a connector, and a mounting portion proximally located relative to said fitting portion and configured to slidably connect an adaptor to said distal tip. The mounting portion is configured to allow a free longitudinal movement of the adaptor relative to the distal tip when the adaptor is connected to the distal tip.

APPLICATOR DEVICE AND APPLICATOR SYSTEM FOR MEDICAMENT CONTAINERS
20230241638 · 2023-08-03 ·

The present disclosure relates to an applicator device for depositing a lubricant onto an inside surface of a barrel of a medicament container. The applicator device includes a sprayer defining a longitudinal direction and sized for insertion into an interior of the barrel along the longitudinal direction. The sprayer is operable to eject the lubricant. A centering element is connected to the sprayer and operably engageable with the barrel in a predefined position or orientation to align the sprayer relative to the barrel.

METHOD OF INJECTING OCTREOTIDE ACETATE INTO THE BODY

A method of providing and/or injecting octreotide acetate to a subject in need thereof includes storing the octreotide acetate in a cartridge of a multi-use multi-dose injector provided with a variable dose setter and actuator. The injector includes a needle configured for subcutaneous administration of the octreotide acetate, the octreotide acetate having a concentration of 2,500 μg/mL. The method further includes providing, on the injector, a plurality of indicia only at prescribed doses of 50 μg, 100 μg, 150 μg and 200 μg settable via the dose setter without indicia between said prescribed doses; and permitting setting of a dose of the octreotide acetate by rotation of the variable dose setter, wherein the injector is configured to provide at least one audible feedback during the rotation.